American Society of Clinical Oncology

Latest stories

1h
News-Medical-Net
Researchers spot molecular key that breast cancer cells use to invade bone marrowdormant for years. Hormone receptor-positive breast cancers are the most commo
Researchers spot molecular key that breast cancer cells use to invade bone marrow
News-Medical-Net / Posted an hour ago
dormant for years. Hormone receptor-positive breast cancers are the most common type of breast cancer, according to the American Society of Clinical Oncology, and grow by exploiting the body's estrogen or progesterone. In human patients, these... Read more
2 related stories
3h
Business Wire
Pathway Genomics Provides Updates for CancerIntercept™ Detect Clinical Programcompany’s third ongoing study for the technology. The company also announced th
Pathway Genomics Provides Updates for CancerIntercept™ Detect Clinical Program
Business Wire / Posted 3 hours ago
company’s third ongoing study for the technology. The company also announced the publication of two abstracts in the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting Proceedings. “The initiation of the thyroid study is an... Read more
23h
express
Could a burst of EXERCISE be as effective as medicine in beating prostate cancer?supplement available treatments, inexpensively." Dr Saad is presenting an over
Could a burst of EXERCISE be as effective as medicine in beating prostate cancer?
express / Posted 23 hours ago
supplement available treatments, inexpensively." Dr Saad is presenting an overview of his Phase 3 clinical trial at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago which begins next week. The trial is being supported... Read more
2 related stories
1d
Dundas Star News
More men with early prostate cancer choosing to avoid treatmentthat concluded that it should be the preferred course for men with small and in
More men with early prostate cancer choosing to avoid treatment
Dundas Star News / Posted yesterday
that concluded that it should be the preferred course for men with small and innocuous-looking tumors. Last year, the American Society of Clinical Oncology issued guidelines with the same advice. The data includes a large new national... Read more
1d
News-Medical-Net
Physical exercise may be as effective as drugs for treating prostate cancer patientsUniversity of Montreal's Department of Surgery. Dr. Saad will present an overv
Physical exercise may be as effective as drugs for treating prostate cancer patients
News-Medical-Net / Posted yesterday
University of Montreal's Department of Surgery. Dr. Saad will present an overview of this Phase 3 clinical trial at the American Society of Clinical Oncology (ASCO) Annual Meeting, which will take place in Chicago from June 3 to 7. The study,... Read more
2 related stories
2d
FOX Business
Ignore Intuitive Surgical, Inc.: Here Are 3 Better StocksRoche. Roche has continued advancing the combination of diagnostics and cancer
Ignore Intuitive Surgical, Inc.: Here Are 3 Better Stocks
FOX Business / Posted 2 days ago
Roche. Roche has continued advancing the combination of diagnostics and cancer therapies. This year's meeting of the American Society of Clinical Oncology will include results from over 200 studies involving 19 of Roche's drugs. The company... Read more
2d
FOX Business
Ignore Intuitive Surgical, Inc.: Here Are 3 Better StocksRoche. Roche has continued advancing the combination of diagnostics and cancer
Ignore Intuitive Surgical, Inc.: Here Are 3 Better Stocks
FOX Business / Posted 2 days ago
Roche. Roche has continued advancing the combination of diagnostics and cancer therapies. This year's meeting of the American Society of Clinical Oncology will include results from over 200 studies involving 19 of Roche's drugs. The company... Read more
2d
FOX Business
3 Reasons Celldex Therapeutics Stock Could Risein Celldex's lineup. 1. 301 + 1401 might equal millions Celldex stock recentl
3 Reasons Celldex Therapeutics Stock Could Rise
FOX Business / Posted 2 days ago
in Celldex's lineup. 1. 301 + 1401 might equal millions Celldex stock recently received an upward nudge after the American Society of Clinical Oncology released a summary from a study the company plans to present in early June. Image... Read more
2d
FOX Business
3 Reasons Celldex Therapeutics Stock Could Rise301 + 1401 might equal millions Continue Reading Below Celldex stock recently
3 Reasons Celldex Therapeutics Stock Could Rise
FOX Business / Posted 2 days ago
301 + 1401 might equal millions Continue Reading Below Celldex stock recently received an upward nudge after the American Society of Clinical Oncology released a summary from a study the company plans to present in early June. Image... Read more
3d
Business Wire
Nordic Nanovector to Host Capital Markets Day in Oslo on 31 May 2016Society of Haematology, the Italian Society of Experimental Haematology, the Am
Nordic Nanovector to Host Capital Markets Day in Oslo on 31 May 2016
Business Wire / Posted 3 days ago
Society of Haematology, the Italian Society of Experimental Haematology, the American Society of Hematology, and the American Society of Clinical Oncology, and has presented his research at more than 250 national and international meetings.... Read more
5d
News-Medical-Net
Study assesses utility of tumor cfDNA as predictor of therapeutic response to immunotherapycopy number instability (CNI) predicts therapeutic response to immunotherapy pr
Study assesses utility of tumor cfDNA as predictor of therapeutic response to immunotherapy
News-Medical-Net / Posted 5 days ago
copy number instability (CNI) predicts therapeutic response to immunotherapy prior to cycle 2”, will be presented at the American Society of Clinical Oncology (‘ASCO’) Annual Meeting 2016 on 5 June 2016 at McCormick Place in Chicago,... Read more
5d
FOX News
Young cancer patients may be unaware of fertility optionsfertility preservation arrangements, the researchers acknowledge in the journal
Young cancer patients may be unaware of fertility options
FOX News / Posted 5 days ago
fertility preservation arrangements, the researchers acknowledge in the journal Cancer. The study was done soon after the American Society of Clinical Oncology (ASCO) recommended in 2006 that oncologists discuss infertility risks with... Read more
6d
News-Medical-Net
AstraZeneca, MedImmune to provide update on extensive oncology pipeline at ASCO 2016and development arm, MedImmune, will provide an update on their extensive oncol
AstraZeneca, MedImmune to provide update on extensive oncology pipeline at ASCO 2016
News-Medical-Net / Posted 6 days ago
and development arm, MedImmune, will provide an update on their extensive oncology pipeline at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, USA, on 3-7 June 2016. Highlights will include new data... Read more
6d
Decclan Chronicle
Precision medicine approach to cancer improves on older methodsthat were published between 2011 and 2013. Their findings were released on Wedn
Precision medicine approach to cancer improves on older methods
Decclan Chronicle / Posted 6 days ago
that were published between 2011 and 2013. Their findings were released on Wednesday and will be presented in full at the American Society of Clinical Oncology meeting in Chicago next month. The precision medicine approach is part of a transition... Read more
3 related stories
6d
Business Wire
Chugai presenteert Japanse resultaten van onderzoek naar Alecensa® op ASCOALK-fusiegenen-positieve niet-kleincellige longkanker (NSCLC) worden gepresente
Chugai presenteert Japanse resultaten van onderzoek naar Alecensa® op ASCO
Business Wire / Posted 6 days ago
ALK-fusiegenen-positieve niet-kleincellige longkanker (NSCLC) worden gepresenteerd op de jaarlijkse bijeenkomst van de American Society of Clinical Oncology (ASCO), die van 3 tot 7 juni plaatsheeft in Chicago. De mondelinge sessie over J-ALEX... Read more
16 related stories
6d
Business Wire
Chugai stellt auf der ASCO Ergebnisse der japanischen Phase-III-Studie zu Alecensa® vornicht kleinzelligen Lungenkrebs (non-small cell lung cancer, NSCLC) im Rahmen d
Chugai stellt auf der ASCO Ergebnisse der japanischen Phase-III-Studie zu Alecensa® vor
Business Wire / Posted 6 days ago
nicht kleinzelligen Lungenkrebs (non-small cell lung cancer, NSCLC) im Rahmen der jährlichen Konferenz der American Society of Clinical Oncology (ASCO), die vom 3. bis 7. Juni in Chicago, Illinois (USA) stattfinden wird, vorgestellt... Read more
714 related stories
6d
Fortune
These New Cancer Drugs Are Helping Patients Live Years Longernumber of patients with advanced lung cancer by at least two years. The result
These New Cancer Drugs Are Helping Patients Live Years Longer
Fortune / Posted 6 days ago
number of patients with advanced lung cancer by at least two years. The results were released on Wednesday ahead of the American Society of Clinical Oncology meeting in Chicago next month. Keytruda and Opdivo are among the first wave of... Read more
28 related stories
6d
CBS News
Immune drug for deadly skin cancer shows long-term survivalwith other immunotherapy drugs, Lichtenfeld said. The Keytruda study was relea
Immune drug for deadly skin cancer shows long-term survival
CBS News / Posted 6 days ago
with other immunotherapy drugs, Lichtenfeld said. The Keytruda study was released at a news briefing organized by the American Society of Clinical Oncology in advance of the group's annual meeting next month in Chicago. The American Cancer... Read more
28 related stories
6d
Medical News Today
Colon cancer: Primary tumor location predicts survivalcancer, the effect they observed in their analysis is much bigger than they exp
Colon cancer: Primary tumor location predicts survival
Medical News Today / Posted 6 days ago
cancer, the effect they observed in their analysis is much bigger than they expected. The study will be presented at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago, IL, June 3-7, 2016. ASCO President Julie M. Vose... Read more
5 related stories
6d
Market Watch
Four reasons for investors to buy biotechnology stocks nowaround the end of year. Market-moving news will also flow at important health-c
Four reasons for investors to buy biotechnology stocks now
Market Watch / Posted 6 days ago
around the end of year. Market-moving news will also flow at important health-care conferences around the corner like the American Society of Clinical Oncology (ASCO) meeting in early June. We’ll also continue to get market-moving product... Read more
6d
CTV News
Immune drug for deadly skin cancer shows long-term survivalwith other immunotherapy drugs, Lichtenfeld said. The Keytruda study was relea
Immune drug for deadly skin cancer shows long-term survival
CTV News / Posted 6 days ago
with other immunotherapy drugs, Lichtenfeld said. The Keytruda study was released at a news briefing organized by the American Society of Clinical Oncology in advance of the group's annual meeting next month in Chicago. The American Cancer... Read more
28 related stories
6d
5KSDK St. Louis
Immune drug for deadly skin cancer shows long-term survivalwith melanoma that had spread to his brain. The study involved 655 patients an
Immune drug for deadly skin cancer shows long-term survival
5KSDK St. Louis / Posted 6 days ago
with melanoma that had spread to his brain. The study involved 655 patients and was released Wednesday in advance of an American Society of Clinical Oncology meeting next month in Chicago. (Copyright 2016 The Associated Press. All rights... Read more
28 related stories
7d
Newsmax
Immune Drug for Deadly Skin Cancer Extends Survivalwith other immunotherapy drugs, Lichtenfeld said. The Keytruda study was relea
Immune Drug for Deadly Skin Cancer Extends Survival
Newsmax / Posted 7 days ago
with other immunotherapy drugs, Lichtenfeld said. The Keytruda study was released at a news briefing organized by the American Society of Clinical Oncology in advance of the group's annual meeting next month in Chicago. The American Cancer... Read more
28 related stories
7d
FOX News
Pfizer's Ibrance delays breast cancer progressionwomen who received letrozole and a placebo, according to a brief summary of dat
Pfizer's Ibrance delays breast cancer progression
FOX News / Posted 7 days ago
women who received letrozole and a placebo, according to a brief summary of data that will be presented next month at the American Society of Clinical Oncology meeting in Chicago. The 10-month difference, deemed by researchers to be highly... Read more
7d
Business Wire
Chronix Biomedical: Changes in Tumor Cell-Free DNA Copy Number Instability (CNI) Predict Therapeutic Response to Immunotherapyinstability (CNI) predicts therapeutic response to immunotherapy prior to cycle
Chronix Biomedical: Changes in Tumor Cell-Free DNA Copy Number Instability (CNI) Predict Therapeutic Response to Immunotherapy
Business Wire / Posted 7 days ago
instability (CNI) predicts therapeutic response to immunotherapy prior to cycle 2” (see link), will be presented at the American Society of Clinical Oncology (‘ASCO’) Annual Meeting 2016 on 5 June 2016 at McCormick Place in Chicago,... Read more
7d
dna
Pfizer's Ibrance shows promise in checking breast cancer progressionimpressive tumour-fighting activity in combinations with other medicines. The
Pfizer's Ibrance shows promise in checking breast cancer progression
dna / Posted 7 days ago
impressive tumour-fighting activity in combinations with other medicines. The new data will be presented next month at the American Society of Clinical Oncology meeting in Chicago. The study tested the combination of utomilumab and Keytruda in a... Read more
3 related stories
7d
dna
How targeting biological markers on tumours effectively shrinks themthat were published between 2011 and 2013. Their findings were released on Wedn
How targeting biological markers on tumours effectively shrinks them
dna / Posted 7 days ago
that were published between 2011 and 2013. Their findings were released on Wednesday and will be presented in full at the American Society of Clinical Oncology meeting in Chicago next month. The precision medicine approach is part of a transition... Read more
3 related stories
7d
The Monterey County Herald
Colon cancer survival rate linked to side of colonnow,” said Dr. Alan Venook, a UC San Francisco professor of medicine who led th
Colon cancer survival rate linked to side of colon
The Monterey County Herald / Posted 7 days ago
now,” said Dr. Alan Venook, a UC San Francisco professor of medicine who led the study, which was released Tuesday by the American Society of Clinical Oncology. With 1,025 patients participating, the largest study of tumor location in colorectal... Read more
5 related stories
7d
Business Wire
Chugai to Present Japanese Phase III Results on Alecensa® at ASCOin ALK fusion gene positive non-small cell lung cancer (NSCLC) patients, will b
Chugai to Present Japanese Phase III Results on Alecensa® at ASCO
Business Wire / Posted 7 days ago
in ALK fusion gene positive non-small cell lung cancer (NSCLC) patients, will be presented at the annual meeting of the American Society of Clinical Oncology (ASCO) which will be held June 3 -7 in Chicago, IL (USA). Results from the J-ALEX study... Read more
7d
Herald Sun
New melanoma drug boosts patient survivalsaid the new Keytruda research was "a big deal". The Keytruda study was releas
New melanoma drug boosts patient survival
Herald Sun / Posted 7 days ago
said the new Keytruda research was "a big deal". The Keytruda study was released at a news briefing organised by the American Society of Clinical Oncology in advance of the group's annual meeting next month in Chicago. The American Cancer... Read more
28 related stories
7d
Adelaide Now
New melanoma drug boosts patient survivalsaid the new Keytruda research was "a big deal". The Keytruda study was releas
New melanoma drug boosts patient survival
Adelaide Now / Posted 7 days ago
said the new Keytruda research was "a big deal". The Keytruda study was released at a news briefing organised by the American Society of Clinical Oncology in advance of the group's annual meeting next month in Chicago. The American Cancer... Read more
28 related stories
7d
The Columbus Dispatch
Location of a colon tumor matters significantly, study findscancers. Goldberg is one of more than a dozen authors whose study will be pres
Location of a colon tumor matters significantly, study finds
The Columbus Dispatch / Posted 7 days ago
cancers. Goldberg is one of more than a dozen authors whose study will be presented in June at the annual meeting of the American Society of Clinical Oncology in Chicago. The research, funded by the National Cancer Institute and three drug... Read more
5 related stories
7d
Weekly Times
Immune drug for deadly skin cancer shows llast year with melanoma that had spread to his brain. The study involved 655 p
Immune drug for deadly skin cancer shows l
Weekly Times / Posted 7 days ago
last year with melanoma that had spread to his brain. The study involved 655 patients and was released on Wednesday in advance of an American Society of Clinical Oncology meeting next month in Chicago. Most popular World Breaking Ne... Read more
28 related stories
7d
Reuters
German Merck, Pfizer immunotherapy shows promise in rare skin cancerresponses with no signs of cancer, while 12 others saw significant tumor shrink
German Merck, Pfizer immunotherapy shows promise in rare skin cancer
Reuters / Posted 7 days ago
responses with no signs of cancer, while 12 others saw significant tumor shrinkage. The data will be presented at the American Society of Clinical Oncology meeting in Chicago next month, and could be used as a basis for seeking U.S.... Read more
3 related stories
7d
The New Zealand Herald
Keytruda helping people survive years, not monthswith other immunotherapy drugs, Lichtenfeld said. The Keytruda study was relea
Keytruda helping people survive years, not months
The New Zealand Herald / Posted 7 days ago
with other immunotherapy drugs, Lichtenfeld said. The Keytruda study was released at a news briefing organized by the American Society of Clinical Oncology in advance of the group's annual meeting next month in Chicago. The American Cancer... Read more
28 related stories
7d
KHQ Spokane
Immune drug for deadly skin cancer shows long-term survivalwith other immunotherapy drugs, Lichtenfeld said. The Keytruda study was relea
Immune drug for deadly skin cancer shows long-term survival
KHQ Spokane / Posted 7 days ago
with other immunotherapy drugs, Lichtenfeld said. The Keytruda study was released at a news briefing organized by the American Society of Clinical Oncology in advance of the group's annual meeting next month in Chicago. The American Cancer... Read more
28 related stories
7d
Perth Now
Immune drug for deadly skin cancer shows llast year with melanoma that had spread to his brain. The study involved 655 p
Immune drug for deadly skin cancer shows l
Perth Now / Posted 7 days ago
last year with melanoma that had spread to his brain. The study involved 655 patients and was released on Wednesday in advance of an American Society of Clinical Oncology meeting next month in Chicago. Most popular World Breaking Ne... Read more
28 related stories
7d
Your Hometown Lima Stations
Immune drug for deadly skin cancer shows long-term survivalwith other immunotherapy drugs, Lichtenfeld said. The Keytruda study was relea
Immune drug for deadly skin cancer shows long-term survival
Your Hometown Lima Stations / Posted 7 days ago
with other immunotherapy drugs, Lichtenfeld said. The Keytruda study was released at a news briefing organized by the American Society of Clinical Oncology in advance of the group's annual meeting next month in Chicago. The American Cancer... Read more
28 related stories
7d
WDIO Duluth
Immune Drug for Deadly Skin Cancer Shows Long-Term Survivalwith other immunotherapy drugs, Lichtenfeld said. The Keytruda study was relea
Immune Drug for Deadly Skin Cancer Shows Long-Term Survival
WDIO Duluth / Posted 7 days ago
with other immunotherapy drugs, Lichtenfeld said. The Keytruda study was released at a news briefing organized by the American Society of Clinical Oncology in advance of the group's annual meeting next month in Chicago. The American Cancer... Read more
28 related stories
7d
KTVN Reno
Immune drug for deadly skin cancer shows long-term survivalwith other immunotherapy drugs, Lichtenfeld said. The Keytruda study was relea
Immune drug for deadly skin cancer shows long-term survival
KTVN Reno / Posted 7 days ago
with other immunotherapy drugs, Lichtenfeld said. The Keytruda study was released at a news briefing organized by the American Society of Clinical Oncology in advance of the group's annual meeting next month in Chicago. The American Cancer... Read more
28 related stories
7d
KTRE Lufkin and Nacogdoches
Immune drug for deadly skin cancer shows long-term survivalwith other immunotherapy drugs, Lichtenfeld said. The Keytruda study was relea
Immune drug for deadly skin cancer shows long-term survival
KTRE Lufkin and Nacogdoches / Posted 7 days ago
with other immunotherapy drugs, Lichtenfeld said. The Keytruda study was released at a news briefing organized by the American Society of Clinical Oncology in advance of the group's annual meeting next month in Chicago. The American Cancer... Read more
28 related stories
7d
WALB Albany
Immune drug for deadly skin cancer shows long-term survivalwith other immunotherapy drugs, Lichtenfeld said. The Keytruda study was relea
Immune drug for deadly skin cancer shows long-term survival
WALB Albany / Posted 7 days ago
with other immunotherapy drugs, Lichtenfeld said. The Keytruda study was released at a news briefing organized by the American Society of Clinical Oncology in advance of the group's annual meeting next month in Chicago. The American Cancer... Read more
28 related stories
7d
KSWO Lawton-Wichita Falls
Immune drug for deadly skin cancer shows long-term survivalwith other immunotherapy drugs, Lichtenfeld said. The Keytruda study was relea
Immune drug for deadly skin cancer shows long-term survival
KSWO Lawton-Wichita Falls / Posted 7 days ago
with other immunotherapy drugs, Lichtenfeld said. The Keytruda study was released at a news briefing organized by the American Society of Clinical Oncology in advance of the group's annual meeting next month in Chicago. The American Cancer... Read more
28 related stories
7d
WTVM 9 Columbus
Immune drug for deadly skin cancer shows long-term survivalwith other immunotherapy drugs, Lichtenfeld said. The Keytruda study was relea
Immune drug for deadly skin cancer shows long-term survival
WTVM 9 Columbus / Posted 7 days ago
with other immunotherapy drugs, Lichtenfeld said. The Keytruda study was released at a news briefing organized by the American Society of Clinical Oncology in advance of the group's annual meeting next month in Chicago. The American Cancer... Read more
28 related stories
7d
The Seattle Times
Immune drug for deadly skin cancer shows long-term survivalwith other immunotherapy drugs, Lichtenfeld said. The Keytruda study was relea
Immune drug for deadly skin cancer shows long-term survival
The Seattle Times / Posted 7 days ago
with other immunotherapy drugs, Lichtenfeld said. The Keytruda study was released at a news briefing organized by the American Society of Clinical Oncology in advance of the group’s annual meeting next month in Chicago. The American Cancer... Read more
28 related stories
7d
WECT 6 Wilmington
Immune drug for deadly skin cancer shows long-term survivalwith melanoma that had spread to his brain. The study involved 655 patients an
Immune drug for deadly skin cancer shows long-term survival
WECT 6 Wilmington / Posted 7 days ago
with melanoma that had spread to his brain. The study involved 655 patients and was released Wednesday in advance of an American Society of Clinical Oncology meeting next month in Chicago. Copyright 2016 The Associated Press. All rights... Read more
10 related stories
7d
WSFA 12 Montgomery
Immune drug for deadly skin cancer shows long-term survivalwith other immunotherapy drugs, Lichtenfeld said. The Keytruda study was relea
Immune drug for deadly skin cancer shows long-term survival
WSFA 12 Montgomery / Posted 7 days ago
with other immunotherapy drugs, Lichtenfeld said. The Keytruda study was released at a news briefing organized by the American Society of Clinical Oncology in advance of the group's annual meeting next month in Chicago. The American Cancer... Read more
28 related stories
7d
9&10 News Cadillac
Immune drug for deadly skin cancer shows long-term survivalwith other immunotherapy drugs, Lichtenfeld said. The Keytruda study was relea
Immune drug for deadly skin cancer shows long-term survival
9&10 News Cadillac / Posted 7 days ago
with other immunotherapy drugs, Lichtenfeld said. The Keytruda study was released at a news briefing organized by the American Society of Clinical Oncology in advance of the group's annual meeting next month in Chicago. The American Cancer... Read more
28 related stories
7d
Business Wire
Tokai Announces Publication of Three Abstracts on Galeterone at the 2016 ASCO Annual Meetinghormonally driven diseases, today announced that data related to galeterone wil
Tokai Announces Publication of Three Abstracts on Galeterone at the 2016 ASCO Annual Meeting
Business Wire / Posted 7 days ago
hormonally driven diseases, today announced that data related to galeterone will be presented in two posters at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting, which will take place from June 3-7, 2016, in Chicago.... Read more
More

People in this news